Crisil ESG Ratings & Analytics Ltd assigns Crisil ESG 57 rating to Mankind Pharma Limited

Crisil ESG Ratings & Analytics Limited, a SEBI registered ESG Rating Provider has voluntarily assigned an ESG rating of "Crisil ESG 57" to Mankind Pharma Limited, based on publicly disclosed information for the fiscal year 2025.

As per the category defined by CRISIL, rating between 51-60 is considered as "adequate".

Shares of Mankind Pharma Limited was last trading in BSE at Rs. 2606.05 as compared to the previous close of Rs. 2600.60. The total number of shares traded during the day was 22713 in over 3197 trades.

The stock hit an intraday high of Rs. 2651.80 and intraday low of 2589.45. The net turnover during the day was Rs. 59531620.00.

Source : Equity Bulls

Keywords

MankindPharma INE634S01028 Pharmaceuticals ESGRating CrisilESG57